文献速递胃肠外科围术期管理与 ERAS

回肠间置联合十二指肠转流袖状胃切除术与标准药物治疗肥胖2型糖尿病的长期病例对照研究

Ileal interposition coupled with duodenal diverted sleeve gastrectomy versus standard medical treatment in type 2 diabetes mellitus obese patients: long-term results of a case-control study.
PubMed 文献 · Surg Endosc · 2018-09-17

本研究为病例对照研究,2008至2011年纳入30例BMI>30的2型糖尿病肥胖患者接受II-DD-SG手术,并与接受标准药物治疗的等量对照组匹配,随访至5年。术后1年26例(86%)达完全缓解,5年时25例随访患者中17例(68%)完全缓解,而药物治疗组仅2例完全缓解(p<0.0001)。结论认为II-DD-SG可诱导肥胖T2DM患者长期完全缓解。

要点

  • II-DD-SG术后1年完全缓解率86%,5年随访完全缓解率68%
  • 药物治疗组仅2例完全缓解,与手术组差异有统计学意义(p<0.0001)
  • 5年时56%患者心血管危险因素获得缓解

核心结论

  • II-DD-SG是有效的外科术式,可使肥胖T2DM患者获得完全且持久的缓解,优于标准药物治疗。

研究设计与样本

  • 病例对照研究,2008至2011年招募30例BMI>30的T2DM肥胖患者接受II-DD-SG手术。
  • 对照组为等量接受标准药物治疗的匹配患者。
  • 主要终点为T2DM缓解,次要终点为体重、BMI及心血管危险因素下降。

主要发现

  • 术后不久即观察到血糖和糖化血红蛋白正常化,随后体重和BMI显著下降。
  • 1年随访时胰岛素抵抗和胰岛素血浆水平显著下降。
  • 1年时26例(86%)完全缓解,2例(6.6%)部分缓解,2例(6.6%)仍为糖尿病。
  • 5年时25例随访患者中17例(68%)完全缓解,56%患者心血管危险因素缓解。
  • 药物治疗组仅2例完全缓解(与II-DD-SG相比p<0.0001)。

临床怎么用

  • 对于肥胖T2DM患者,II-DD-SG可能作为药物治疗之外的代谢手术选择,需评估长期缓解与心血管风险改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomized controlled trials have demonstrated that bariatric surgery is effective in obtaining remission of type 2 diabetes mellitus (T2DM) in obese patients, yet no data exist in the literature from prospective studies with ileal interposition with duodenal diversion sleeve gastrectomy (II-DD-SG). The aim of this case-control study is to investigate if II-DD-SG is superior to medical treatment in T2DM obese patients. METHODS: Thirty obese patients (BMI > 30) affected by T2DM were recruited for surgery (II-DD-SG) between 2008 and 2011 and were matched with an equal control group which received standard medical treatment. Anthropometric measures, glucose metabolism, cardiovascular risk factors were determined baseline and during follow-up. The primary end point was T2DM remission; reduction of body weight, BMI, and cardiovascular risk factors were secondary end-points. RESULTS: Shortly after II-DD-SG, normalization of glucose plasma levels and glycated hemoglobin was observed followed by a significant decrease in body weight and BMI. At one-year follow-up, insulin resistance strongly declined as did insulin plasma levels. Complete remission was observed in 26 patients (86%); 2 (6.6%) had partial remission, and two (6.6%) were still diabetic. After 5 years, 17 of 25 patients on follow-up (68%) showed complete remission of T2DM and 56% had remission of cardiovascular risk factors. Only two patients receiving medical treatment showed complete remission of T2DM (p < 0.0001 versus II-DD-SG). No significant changes of anthropometric parameters and lipid metabolism were recorded. CONCLUSIONS: II-DD-SG is an effective surgical procedure, able to induce complete and prolonged remission of T2DM in obese patients as opposed to medical treatment.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Foschi D, Sorrentino L, Tubazio I, et al. Ileal interposition coupled with duodenal diverted sleeve gastrectomy versus standard medical treatment in type 2 diabetes mellitus obese patients: long-term results of a case-control study. Surg Endosc. 2018. PMID: 30225603. doi:10.1007/s00464-018-6443-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。